Relapsed disease and aspects of undetectable MRD and treatment discontinuation

Continuous treatment vs fixed duration of monotherapies and combinations of targeted agents are treatment options in relapsed chronic lymphocytic leukemia. The optimal choice of relapse treatment is dependent on the prior frontline therapy, duration of remission after frontline, genetic markers, and...

Full description

Saved in:
Bibliographic Details
Published in:Hematology Am Soc Hematol Educ Program
Main Authors: Eichhorst, Barbara, Fürstenau, Moritz, Hallek, Michael
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2019
Subjects:
Response Comes of Age in Chronic Lymphocytic Leukemia
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913464/
https://ncbi.nlm.nih.gov/pubmed/31808867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000070
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items